tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SLRN Stock Latest News

SLRN Earnings this Week: How Will it Perform?
Pre-EarningsSLRN Earnings this Week: How Will it Perform?
3d ago
SLRN
Acelyrin adopts limited-duration stockholder rights plan
PremiumThe Fly
Acelyrin adopts limited-duration stockholder rights plan
14d ago
SLRN
Acelyrin says Concentra indication not expected to result in superior proposal
PremiumThe Fly
Acelyrin says Concentra indication not expected to result in superior proposal
23d ago
ALMS
SLRN
Acelyrin, Alumis reaffirm strategic, financial rationale of proposed merger
PremiumThe Fly
Acelyrin, Alumis reaffirm strategic, financial rationale of proposed merger
23d ago
ALMS
SLRN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
CG
BLUE
Acelyrin confirms unsolicited indication of interest from Concentra Biosciences
PremiumThe FlyAcelyrin confirms unsolicited indication of interest from Concentra Biosciences
1M ago
ALMS
SLRN
Alumis price target lowered to $26 from $32 at Oppenheimer
Premium
The Fly
Alumis price target lowered to $26 from $32 at Oppenheimer
2M ago
ALMS
SLRN
ACELYRIN, INC. Announces Merger with Alumis Inc.
Premium
Company Announcements
ACELYRIN, INC. Announces Merger with Alumis Inc.
2M ago
8K
SLRN
Acelyrin Inc trading resumes
PremiumThe Fly
Acelyrin Inc trading resumes
2M ago
SLRN
Alumis, Acelyrin to merge in all-stock transaction
PremiumThe Fly
Alumis, Acelyrin to merge in all-stock transaction
2M ago
ALMS
SLRN
Acelyrin Inc trading halted, news pending
PremiumThe Fly
Acelyrin Inc trading halted, news pending
2M ago
SLRN
ACELYRIN, INC. Ends Key Agreement with Affibody
PremiumCompany Announcements
ACELYRIN, INC. Ends Key Agreement with Affibody
2M ago
8K
SLRN
Acelyrin price target lowered to $3 from $6 at Citi
PremiumThe FlyAcelyrin price target lowered to $3 from $6 at Citi
3M ago
SLRN
Acelyrin sinks 39% to $2.12 after thyroid eye disease data update
Premium
The Fly
Acelyrin sinks 39% to $2.12 after thyroid eye disease data update
3M ago
SLRN
Wedbush stays positive on Viridian shares after Acelyrin data
Premium
The Fly
Wedbush stays positive on Viridian shares after Acelyrin data
3M ago
SLRN
VRDN
Acelyrin price target lowered to $6 from $8 at H.C. Wainwright
PremiumThe Fly
Acelyrin price target lowered to $6 from $8 at H.C. Wainwright
3M ago
SLRN
Acelyrin announces additional lonigutamab data, design for LONGITUDE program
PremiumThe Fly
Acelyrin announces additional lonigutamab data, design for LONGITUDE program
3M ago
SLRN
Acelyrin price target lowered to $5 from $6 at Morgan Stanley
PremiumThe Fly
Acelyrin price target lowered to $5 from $6 at Morgan Stanley
3M ago
SLRN
Acelyrin price target lowered to $13 from $15 at Wells Fargo
PremiumThe Fly
Acelyrin price target lowered to $13 from $15 at Wells Fargo
4M ago
SLRN
ACELYRIN Faces CFO Resignation and Trial Setback
PremiumCompany AnnouncementsACELYRIN Faces CFO Resignation and Trial Setback
4M ago
8K
SLRN
Acelyrin Inc trading resumes
Premium
The Fly
Acelyrin Inc trading resumes
4M ago
SLRN
Acelyrin announces izokibep trial did not meet primary endpoint
Premium
The Fly
Acelyrin announces izokibep trial did not meet primary endpoint
4M ago
SLRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >